MDT — Medtronic Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Medtronic, fiscal year end - April 24th, USD millions except per share, conversion factor applied.

	2022 April 29th	2023 April 28th	2024 April 26th	2025 April 25th	2026 April 24th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	8-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	31,686	31,227	32,364	33,537	36,364
Cost of Revenue
Gross Profit	21,715	20,605	21,273	21,931	23,776
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	25,934	25,795	27,220	27,582	29,897
Operating Profit	5,752	5,432	5,144	5,955	6,467
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,517	5,364	4,837	5,628	6,136
Provision for Income Taxes
Net Income After Taxes	5,061	3,784	3,704	4,692	4,837
Minority Interest
Net Income Before Extraordinary Items
Net Income	5,039	3,758	3,676	4,663	4,800
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,039	3,758	3,676	4,662	4,801
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.59	2.94	3.95	4.18	4.04
Dividends per Share